BIOCOMPATIBLE NANOPARTICLES AND USES THEREOF
Summary
A process for preparing polymeric monodispersed reduced nanohydrogels (NHGs) comprises combining monomers, macromonomer, a cross-linker, and a surfactant to obtain a precursor mixture; heating the precursor mixture to at least 40°C; adding an initiator; and performing an NHG reduction step. The application US20260108625A1 was published on April 23, 2026, naming inventors Gerardo BYK, Eswaran LAKSHMANAN, Cyril Joseph COHEN, and Maria RADMAN, with a filing date of September 27, 2023.
About this source
USPTO classification A61K covers pharmaceutical preparations: formulations, dosage forms, combination therapies, delivery systems, and the vehicles that carry active ingredients. Every newly published application in A61K lands in this feed, around 245 a month. Applications publish 18 months after filing, so this feed reveals what pharma formulators at major sponsors and generics were working on in the prior year and a half. Watch this if you compete in drug formulation, file freedom-to-operate analyses, scout competitive drug products before clinical readouts, or follow novel delivery platforms like nanoparticles, lipid carriers, and long-acting injectables.
What changed
USPTO published patent application US20260108625A1 titled 'Biocompatible Nanoparticles and Uses Thereof' on April 23, 2026. The application discloses a process for preparing polymeric monodispersed reduced nanohydrogels (NHGs) through a four-step method involving monomer combination, controlled heating, initiator addition, and NHG reduction. CPC classifications A61K 48/0041 and A61K 9/06 indicate pharmaceutical and topical/dermatological applications.
Patent applications are informational publications and do not create immediate compliance obligations for competitors or industry. Entities developing similar nanoparticle technologies should monitor this application's prosecution to assess potential freedom-to-operate implications upon issuance.
Archived snapshot
Apr 24, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
BIOCOMPATIBLE NANOPARTICLES AND USES THEREOF
Application US20260108625A1 Kind: A1 Apr 23, 2026
Inventors
Gerardo BYK, Eswaran LAKSHMANAN, Cyril Joseph COHEN, Maria RADMAN
Abstract
A process for preparing polymeric monodispersed reduced nanohydrogels (NHGs) comprises: a) combining monomers, macromonomer, a cross-linker, and a surfactant to obtain a precursor mixture; b) heating the precursor mixture to a temperature of at least 40° C.; c) adding an initiator to the precursor mixture to obtain polymeric NHG; and d) performing an NHG reduction step. Polymeric monodispersed reduced NHGs and methods of use thereof are also disclosed.
CPC Classifications
A61K 48/0041 A61K 9/06
Filing Date
2023-09-27
Application No.
19117610
Mentioned entities
Related changes
Get daily alerts for USPTO Patent Applications - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.